Chandan Seth Nanda

Chandan Seth Nanda has a diverse work experience in the field of target and drug discovery, cancer research, and scientific writing. They are currently serving as the Director of Target and Drug Discovery at Pear Bio since April 2023. Prior to this, they worked as the Founding (Lead) Scientist of Target & Drug Discovery at the same company from January 2022 to April 2023.

Chandan has also been associated with various organizations in the medical and scientific fields. They are an Associate Member of the Royal Society of Medicine since December 2022. They have served as an Ambassador for the European Association for Cancer Research (EACR) starting from August 2020. Additionally, they are a member of the British Association for Cancer Research since July 2019.

During their time at The Francis Crick Institute, Chandan held multiple roles. They were a Visiting Scientist from January 2022 to June 2023 and a Postdoctoral Research Scientist from December 2017 to December 2021. In the latter role, they focused on studying tumor metabolism and cancer heterogeneity, particularly in breast tissue, with an emphasis on oncogene-driven cancers.

Chandan also has experience in editorial work. They served as the Editor-in-Chief for Science Innovation Union from August 2020 to August 2021. They have also worked as an Editorial Writer for the same organization from 2016 to March 2019.

Additionally, Chandan has been associated with King's College as an Associate Staff from 2018 to 2020 and with UCL as an Associate Staff from December 2017 to September 2019. They have also worked as an Associate at Career Insight from June 2017 to November 2017.

Overall, Chandan Seth Nanda has a strong background in target and drug discovery, cancer research, and scientific writing.

Chandan Seth Nanda completed their schooling at Cambridge School in New Delhi, India, from 1991 to 2004, with a focus on science. Chandan then pursued a Bachelor's (Hons) degree in Biochemistry from Delhi University, graduating in 2007. Following this, they obtained a Master's degree in Biotechnology from Jamia Hamdard University between 2007 and 2009. Continuing their education, Chandan completed a PhD in Oncology and Cancer Biology from the University of Geneva, earning their degree in 2015. Chandan later engaged in a post-doctoral fellowship at the University of Oxford, specializing in Biotechnology, Cancer heterogeneity & therapeutics, and Pharmacogenomics. Additionally, they pursued a post-graduate diploma in Intellectual Property Rights from Indira Gandhi National Open University.